WATSON LABS TEVA FDA Approval ANDA 078634

ANDA 078634

WATSON LABS TEVA

FDA Drug Application

Application #078634

Application Sponsors

ANDA 078634WATSON LABS TEVA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL50MG0BICALUTAMIDEBICALUTAMIDE

FDA Submissions

ORIG1AP2009-08-28
LABELING; LabelingSUPPL4AP2016-05-10STANDARD
LABELING; LabelingSUPPL5AP2016-05-10STANDARD
LABELING; LabelingSUPPL6AP2019-02-07STANDARD

Submissions Property Types

ORIG1Null7
SUPPL4Null15
SUPPL5Null15
SUPPL6Null7

TE Codes

001PrescriptionAB

CDER Filings

WATSON LABS TEVA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 78634
            [companyName] => WATSON LABS TEVA
            [docInserts] => ["",""]
            [products] => [{"drugName":"BICALUTAMIDE","activeIngredients":"BICALUTAMIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"BICALUTAMIDE","submission":"BICALUTAMIDE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.